ALLIQUA, INC. (ALQA)

Recent Material Events for ALLIQUA, INC.
Date Description
Jan 09, 2013 On January 7, 2013, James Sapirstein, President and CEO, of Alliqua, Inc. (the “Company”) presented an overview of the Company’s business and recent developments at Biotech Showcase 2013, held January 7-9, 2013, at the Parc 55 Wyndh
Dec 20, 2012 On December 19, 2012, Alliqua, Inc. (the “Company”) held its annual meeting of shareholders. The following three proposals were submitted to the shareholders at the Meeting:
Dec 20, 2012 On December 19, 2012, Alliqua, Inc. (the “Company”) held its annual meeting of shareholders. The following three proposals were submitted to the shareholders at the Meeting:
Dec 05, 2012 On November 29, 2012 (the “Johnson Effective Date”), the Company appointed David I. Johnson as a Class I director of the Board, with a term expiring at the 2013 annual meeting of stockholders, as well as executive chairman of Aquamed Tech
Dec 03, 2012 On November 27, 2012, each of Richard Rosenblum and David Stefansky resigned as co-executive chairman of Alliqua, Inc. (the “Company”) and the Company’s board of directors (the “Board”) appointed Dr. Jerome Zeldis, a Cla
Dec 03, 2012 On November 27, 2012, each of Richard Rosenblum and David Stefansky resigned as co-executive chairman of Alliqua, Inc. (the “Company”) and the Company’s board of directors (the “Board”) appointed Dr. Jerome Zeldis, a Cla
Nov 14, 2012 On November 8, 2012, we entered into a securities purchase agreement (the “ Securities Purchase Agreement ”) with certain accredited investors (the “ Investors ”) pursuant to which we issued, in the aggregate, (i) 16,300,000 s
Nov 14, 2012 On November 8, 2012, we entered into a securities purchase agreement (the “ Securities Purchase Agreement ”) with certain accredited investors (the “ Investors ”) pursuant to which we issued, in the aggregate, (i) 16,300,000 s
Oct 03, 2012 On September 27, 2012, the Board of Directors (the “Board”) of Alliqua, Inc. (the “Company”) appointed James Sapirstein as the Company’s Chief Executive Officer and a Class I member of the Board with a term expiring at t
Oct 03, 2012 On September 27, 2012, the Board of Directors (the “Board”) of Alliqua, Inc. (the “Company”) appointed James Sapirstein as the Company’s Chief Executive Officer and a Class I member of the Board with a term expiring at t